TAT and ischemia: As expected, administration of Tat-NTS peptide alone, or administration of Tat-NTS peptide under the premise of overexpression of ANXA1-WT, or only overexpression of ANXA1-SUMO2 in microglia of model mice, can greatly protect against ischemia-induced neurological impairment.